GJA6P

Across TCGA pan-cancer cohorts, GJA6P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated GJA6P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GJA6P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated GJA6P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

OV, LUSC, and UVM are the cancer types where GJA6P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.271	0.136	.004	90	view →
LUSC	DFS	Tertile	III,IV	0.187	0.581	<.001	78	view →
UVM	OS	Tertile	All	0.104	0.834	<.001	63	view →
LIHC	OS	Tertile	III,IV	0.194	0.654	.003	27	view →
KIRC	DFS	Tertile	IV	0.198	0.385	.015	25	view →
LGG	DFS	Tertile	All	0.701	0.858	.007	15	view →
THCA	OS	Tertile	III,IV	0.240	0.795	.013	9	view →
ACC	OS	Tertile	All	0.375	0.722	.039	6	view →
PRAD	OS	Tertile	All	0.660	0.915	.043	6	view →
SARC	OS	Tertile	All	0.514	0.749	.016	6	view →
KIRP	OS	Tertile	III,IV	0.558	0.841	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

GJA6P–OV (DFS)

Open the OV breakdown →